1. Early anthra-cycline cardiotoxicity;Bristow;Am J Med,1978
2. Risk factors for doxorubicin induced congestive heart failure;Von Hoff;Ann Intern Med,1979
3. Daunomycin-induced cardiotoxicity in children and adults;Von Hoff;Am J Med,1977
4. Bristow MR. Pathophysiologic basis for cardiac monitoring in patients receiving anthracyclines. In: Crooke ST, Reich SD, editors. Anthracyclines: Current status and new developments. Academic Press 1980:255-270.
5. Steinherz L, Murphy ML, Steinherz P et al. Long-term cardiac follow up 4-13 years post anthracycline therapy. In: Doyle E, Engle MA, Gersony W, Rashkin W, Talner N, editors. Pediatric Cardiology. New York: Springer Verlag, 1986:1058–1061.